| Brittany O'steen Morrow, CRNA | |
|
2510 Lakeland Dr, Flowood, MS 39232-9513 | |
| (601) 355-1234 | |
| (601) 352-4882 |
| Full Name | Brittany O'steen Morrow |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 11 Years |
| Location | 2510 Lakeland Dr, Flowood, Mississippi |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124468061 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | R880018 (Mississippi) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gastrointestinal Associates Pa | 5294795241 | 90 |
News Archive
Dr. Richard Dolinar, chairman of the Alliance for Safe Biologic Medicines (Alliance) outlined five areas of concern that the U.S. Food and Drug Administration (FDA) should resolve before they allow biosimilar medications on the U.S. drug market in prepared testimony for the FDA's May 11th public hearing. The event addressed the FDA's recent draft guidelines for the development of biosimilar products.
A team led by the University of South Florida (USF Health) Morsani College of Medicine and the leading national hereditary breast and ovarian cancer advocacy organization, FORCE (Facing Our Risk of Cancer Empowered), has received a $960,026 award from the Patient-Centered Outcomes Research Institute (PCORI) to develop and expand a health data network that will be part of PCORnet: the National Patient-Centered National Clinical Research Network.
Amorfix Life Sciences, a company focused on treatments and diagnostics for misfolded protein diseases, today announced it has achieved 100% specificity (no reproducible false positive results) upon testing 19,000 blood donations for variant Creutzfeldt-Jakob Disease ("vCJD") with the EP-vCJD(TM) Blood Screening Assay at l'Etablissement Français du Sang de Pyrénées Méditerrannée ("EFS-PM") in Montpellier, France.
The Food and Drug Administration (FDA) is warning consumers not to drink certain brands of mineral water imported from Armenia due to the risk of exposure to arsenic, a toxic substance and known cause of cancer in humans.
A new book edited by Chad D. Lavender, M.D., an assistant professor of orthopedic surgery at the Marshall University Joan C. Edwards School of Medicine, explores novel minimally invasive techniques and technology for treating sports medicine and orthopedic injuries.
› Verified 7 days ago
| Entity Name | Gastrointestinal Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093765604 PECOS PAC ID: 5294795241 Enrollment ID: O20041013001263 |
News Archive
Dr. Richard Dolinar, chairman of the Alliance for Safe Biologic Medicines (Alliance) outlined five areas of concern that the U.S. Food and Drug Administration (FDA) should resolve before they allow biosimilar medications on the U.S. drug market in prepared testimony for the FDA's May 11th public hearing. The event addressed the FDA's recent draft guidelines for the development of biosimilar products.
A team led by the University of South Florida (USF Health) Morsani College of Medicine and the leading national hereditary breast and ovarian cancer advocacy organization, FORCE (Facing Our Risk of Cancer Empowered), has received a $960,026 award from the Patient-Centered Outcomes Research Institute (PCORI) to develop and expand a health data network that will be part of PCORnet: the National Patient-Centered National Clinical Research Network.
Amorfix Life Sciences, a company focused on treatments and diagnostics for misfolded protein diseases, today announced it has achieved 100% specificity (no reproducible false positive results) upon testing 19,000 blood donations for variant Creutzfeldt-Jakob Disease ("vCJD") with the EP-vCJD(TM) Blood Screening Assay at l'Etablissement Français du Sang de Pyrénées Méditerrannée ("EFS-PM") in Montpellier, France.
The Food and Drug Administration (FDA) is warning consumers not to drink certain brands of mineral water imported from Armenia due to the risk of exposure to arsenic, a toxic substance and known cause of cancer in humans.
A new book edited by Chad D. Lavender, M.D., an assistant professor of orthopedic surgery at the Marshall University Joan C. Edwards School of Medicine, explores novel minimally invasive techniques and technology for treating sports medicine and orthopedic injuries.
› Verified 7 days ago
| Entity Name | Willow Anesthesia Services, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205169521 PECOS PAC ID: 9234279183 Enrollment ID: O20091228000308 |
News Archive
Dr. Richard Dolinar, chairman of the Alliance for Safe Biologic Medicines (Alliance) outlined five areas of concern that the U.S. Food and Drug Administration (FDA) should resolve before they allow biosimilar medications on the U.S. drug market in prepared testimony for the FDA's May 11th public hearing. The event addressed the FDA's recent draft guidelines for the development of biosimilar products.
A team led by the University of South Florida (USF Health) Morsani College of Medicine and the leading national hereditary breast and ovarian cancer advocacy organization, FORCE (Facing Our Risk of Cancer Empowered), has received a $960,026 award from the Patient-Centered Outcomes Research Institute (PCORI) to develop and expand a health data network that will be part of PCORnet: the National Patient-Centered National Clinical Research Network.
Amorfix Life Sciences, a company focused on treatments and diagnostics for misfolded protein diseases, today announced it has achieved 100% specificity (no reproducible false positive results) upon testing 19,000 blood donations for variant Creutzfeldt-Jakob Disease ("vCJD") with the EP-vCJD(TM) Blood Screening Assay at l'Etablissement Français du Sang de Pyrénées Méditerrannée ("EFS-PM") in Montpellier, France.
The Food and Drug Administration (FDA) is warning consumers not to drink certain brands of mineral water imported from Armenia due to the risk of exposure to arsenic, a toxic substance and known cause of cancer in humans.
A new book edited by Chad D. Lavender, M.D., an assistant professor of orthopedic surgery at the Marshall University Joan C. Edwards School of Medicine, explores novel minimally invasive techniques and technology for treating sports medicine and orthopedic injuries.
› Verified 7 days ago
| Entity Name | R&r Anesthesia Services Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114494796 PECOS PAC ID: 2163761339 Enrollment ID: O20190306000065 |
News Archive
Dr. Richard Dolinar, chairman of the Alliance for Safe Biologic Medicines (Alliance) outlined five areas of concern that the U.S. Food and Drug Administration (FDA) should resolve before they allow biosimilar medications on the U.S. drug market in prepared testimony for the FDA's May 11th public hearing. The event addressed the FDA's recent draft guidelines for the development of biosimilar products.
A team led by the University of South Florida (USF Health) Morsani College of Medicine and the leading national hereditary breast and ovarian cancer advocacy organization, FORCE (Facing Our Risk of Cancer Empowered), has received a $960,026 award from the Patient-Centered Outcomes Research Institute (PCORI) to develop and expand a health data network that will be part of PCORnet: the National Patient-Centered National Clinical Research Network.
Amorfix Life Sciences, a company focused on treatments and diagnostics for misfolded protein diseases, today announced it has achieved 100% specificity (no reproducible false positive results) upon testing 19,000 blood donations for variant Creutzfeldt-Jakob Disease ("vCJD") with the EP-vCJD(TM) Blood Screening Assay at l'Etablissement Français du Sang de Pyrénées Méditerrannée ("EFS-PM") in Montpellier, France.
The Food and Drug Administration (FDA) is warning consumers not to drink certain brands of mineral water imported from Armenia due to the risk of exposure to arsenic, a toxic substance and known cause of cancer in humans.
A new book edited by Chad D. Lavender, M.D., an assistant professor of orthopedic surgery at the Marshall University Joan C. Edwards School of Medicine, explores novel minimally invasive techniques and technology for treating sports medicine and orthopedic injuries.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brittany O'steen Morrow, CRNA 2510 Lakeland Dr, Flowood, MS 39232-9513 Ph: (601) 355-1234 | Brittany O'steen Morrow, CRNA 2510 Lakeland Dr, Flowood, MS 39232-9513 Ph: (601) 355-1234 |
News Archive
Dr. Richard Dolinar, chairman of the Alliance for Safe Biologic Medicines (Alliance) outlined five areas of concern that the U.S. Food and Drug Administration (FDA) should resolve before they allow biosimilar medications on the U.S. drug market in prepared testimony for the FDA's May 11th public hearing. The event addressed the FDA's recent draft guidelines for the development of biosimilar products.
A team led by the University of South Florida (USF Health) Morsani College of Medicine and the leading national hereditary breast and ovarian cancer advocacy organization, FORCE (Facing Our Risk of Cancer Empowered), has received a $960,026 award from the Patient-Centered Outcomes Research Institute (PCORI) to develop and expand a health data network that will be part of PCORnet: the National Patient-Centered National Clinical Research Network.
Amorfix Life Sciences, a company focused on treatments and diagnostics for misfolded protein diseases, today announced it has achieved 100% specificity (no reproducible false positive results) upon testing 19,000 blood donations for variant Creutzfeldt-Jakob Disease ("vCJD") with the EP-vCJD(TM) Blood Screening Assay at l'Etablissement Français du Sang de Pyrénées Méditerrannée ("EFS-PM") in Montpellier, France.
The Food and Drug Administration (FDA) is warning consumers not to drink certain brands of mineral water imported from Armenia due to the risk of exposure to arsenic, a toxic substance and known cause of cancer in humans.
A new book edited by Chad D. Lavender, M.D., an assistant professor of orthopedic surgery at the Marshall University Joan C. Edwards School of Medicine, explores novel minimally invasive techniques and technology for treating sports medicine and orthopedic injuries.
› Verified 7 days ago
Miss Amy Lauren Steele, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1026 N Flowood Dr, Flowood, MS 39232 Phone: 601-454-2401 Fax: 601-936-9971 | |
Michael Brian Nobles, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2510 Lakeland Dr, Flowood, MS 39232 Phone: 601-355-1234 Fax: 601-326-3566 | |
Aimee Renaudin, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1030 River Oaks Drive, Flowood, MS 39232 Phone: 334-279-1450 Fax: 334-279-1660 | |
Nina E. Mclain, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2510 Lakeland Dr, Flowood, MS 39232 Phone: 601-355-1234 Fax: 601-326-3559 | |
Karen Lynne Whitwer, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 2550 Flowood Dr, Suite 400, Flowood, MS 39232 Phone: 601-933-9521 Fax: 601-933-9525 | |
Lacey W Whittington, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1026 N Flowood Dr, Flowood, MS 39232 Phone: 601-932-1000 |